GLPG Stock Recent News

Galapagos NV (NASDAQ:GLPG ) Q2 2022 Earnings Conference Call August 5, 2022 8:00 AM ET Company Participants Sofie Van Gijsel - Senior Director of Investor Relations Paul Stoffels - Chief Executive Officer Bart Filius - Chief Operating Officer & Chief Financial Officer Walid Abi-Saab - Chief Medical Officer Michele Manto - Chief Commercial Officer Conference Call Participants Brian Abrahams - RBC Capital Markets Jason Gerberry - Bank of America Charlie Mabbutt - Bernstein James Gordon - JPMorgan Matthew Harrison - Morgan Stanley Phil Nadeau - Cowen & Co Jeroen Van den Bossche - KBC Securities Dane Leone - Raymond James Rosie Turner - Jefferies Operator Good day and thank you for standing by. Welcome to the First Half 2022 Financial Results Conference Call.

Here is how Galapagos NV (GLPG) and Immunocore Holdings PLC Sponsored ADR (IMCR) have performed compared to their sector so far this year.

The consensus price target hints at a 28.3% upside potential for Galapagos NV (GLPG). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Here is how Galapagos NV (GLPG) and Patterson Cos. (PDCO) have performed compared to their sector so far this year.

Amid the biotech bear market, there are companies that are trading on a deep bargain, yet you should be extremely careful before averaging down. Though I noticed the fundamental changes in Galapagos, I gave the company a year to turn around.

Here is how Galapagos NV (GLPG) and Halozyme Therapeutics (HALO) have performed compared to their sector so far this year.

Galapagos NV (NASDAQ:GLPG ) Q1 2022 Results Conference Call May 6, 2022 8:00 AM ET Company Participants Sofie Van Gijsel - Senior Director, Investor Relations Paul Stoffels - Chief Executive Officer Bart Filius - Chief Operating Officer & Chief Financial Officer Walid Abi-Saab - Chief Medical Officer Michele Manto - Chief Commercial Officer Conference Call Participants Matthew Harrison - Morgan Stanley Dane Leone - Raymond James Brian Abrahams - RBC Capital Markets Charlie Mabbutt - Bernstein Jason Gerberry - Bank of America Phil Nadeau - Cowen & Co Peter Verdult - Citi Peter Welford - Jefferies Jeroen Van den Bossche - KBC Securities Operator Good day, and thank you for standing by. Welcome to the Galapagos Financial Results Q1 2022 Conference Call.

Here is how Galapagos NV (GLPG) and MedAvail Holdings, Inc. (MDVL) have performed compared to their sector so far this year.

Galapagos NV (GLPG) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Daniel Skjeldam, CEO of Hurtigruten Group, talks about why now is the right time to expand its portfolio of destinations and ships. He also shares the organization's deep focus on more sustainable and diverse operations and what is in store for the growing brand.